Exercise improves symptoms by changing the way the brain works Date 18 January 2022 Researchers in the Netherlands discover that regular exercise may improve Parkinson’s symptoms by creating connections between areas of the brain affected by the condition.
Working together to drive forward race equality in research Date 21 December 2021 We’ve teamed up with leading patient engagement organisations COUCH Health and Egality Health to make Parkinson’s research more accessible, relevant and inclusive.
Take part in groundbreaking research to test drugs to combat coronavirus Date 14 December 2021 If you test positive for coronavirus, you may be able to take part in a UK-wide trial to find out if antiviral drugs can help people recover faster.
Caption Research pipette Parkinson's protein test could lead to earlier and better diagnosis Date 13 December 2021 Scientists have shown a pioneering test could diagnose Parkinson's correctly in its early stages.
We're investing up to £3m in drugs that could slow the progression of Parkinson’s Date 6 December 2021 We’re investing in research into inflammation that could help develop drugs that slow the progression of Parkinson’s, something no current medication can do.
Clinical trial of new dyskinesia drug starts in Sweden Date 30 November 2021 The first participant has been recruited to a pioneering clinical trial which is testing a new drug called NLX-112 to investigate its potential for people with Parkinson’s.
Working together to put patients at the heart of Parkinson's research Date 26 November 2021 UCB, a global pharmaceutical company, has joined forces with Parkinson's UK, and the Parkinson's Foundation in the US, to establish a Patient Engagement Council for Parkinson's Research.
Launch of a new toolkit for researchers Date 2 November 2021 We’ve developed an interactive communications toolkit to help researchers in all areas of health research to keep in touch with their participants. It is supported by the Health Research Authority (HRA) as part of the Make It Public strategy.
ADHD drug shows promise for improving cognition in Parkinson’s Date 17 August 2021 Results show that atomoxetine, a drug used to treat attention deficit hyperactivity disorder (ADHD), could improve thinking and impulsiveness in Parkinson’s.
Compound found in fruit shows promise for Parkinson’s Date 29 July 2021 Researchers in the United States have shown that a compound found in fruit - farnesol - has the potential to play a protective role to dopamine-producing brain cells.
